
What are the predictors of Fabry’s disease progression despite enzyme therapy?
Heart Podcast
Understanding Fabry's Disease and Its Impact on Heart Health
This chapter explores Fabry's disease, an X-linked lysosomal disorder caused by a deficiency in the alpha-galactosidase enzyme. It emphasizes the significance of early diagnosis, its systemic impacts, particularly on heart health, and discusses recent advancements in recombinant enzyme therapies for treatment.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.